Thompson Jaye's Form 4 filing
Greenwich LifeSciences, Inc. (GLSI) · filed Jan 19, 2022
- Accession no.
- 0001493152-22-001542
- Filed
- Jan 19, 2022
- Trade date
- Jan 18, 2022
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction. Open-market purchases total $9.44K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Thompson JayeCIK 0001476971 | Officer (VP Clinical Reg. Affairs) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 18, 2022 | Common Stock | PPurchaseAcquired | +500 | $18.87 | +$9,435 | 254,495 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.